SampleID | Type | Habitat | Year | Sequence type | MNS1 | MAS2 |
---|---|---|---|---|---|---|
S_SRP338297.SRR16016307 | Oral | Saliva | 2020 | 16S_V3-V4 | - | - |
S_SRP338297.SRR16016308 | Oral | Saliva | 2020 | 16S_V3-V4 | - | - |
S_SRP338297.SRR16016309 | Oral | Saliva | 2020 | 16S_V3-V4 | - | - |
S_SRP338297.SRR16016310 | Oral | Saliva | 2020 | 16S_V3-V4 | - | - |
S_SRP338297.SRR16016311 | Oral | Saliva | 2020 | 16S_V3-V4 | - | - |
S_SRP338297.SRR16016312 | Oral | Saliva | 2020 | 16S_V3-V4 | - | - |
S_SRP338297.SRR16016313 | Oral | Saliva | 2020 | 16S_V3-V4 | - | - |
S_SRP338297.SRR16016314 | Oral | Saliva | 2020 | 16S_V3-V4 | - | - |
S_SRP338297.SRR16016315 | Oral | Saliva | 2020 | 16S_V3-V4 | - | - |
S_SRP338297.SRR16016316 | Oral | Saliva | 2020 | 16S_V3-V4 | - | - |
S_SRP338297.SRR16016317 | Oral | Oral | 2020 | 16S_V3-V4 | - | - |
S_SRP338297.SRR16016318 | Oral | Saliva | 2020 | 16S_V3-V4 | - | - |
S_SRP338297.SRR16016319 | Oral | Saliva | 2020 | 16S_V3-V4 | - | - |
S_SRP338297.SRR16016320 | Oral | Saliva | 2020 | 16S_V3-V4 | - | - |
S_SRP338297.SRR16016321 | Oral | Saliva | 2020 | 16S_V3-V4 | - | - |
S_SRP338297.SRR16016322 | Oral | Saliva | 2020 | 16S_V3-V4 | - | - |
S_SRP338297.SRR16016323 | Oral | Saliva | 2020 | 16S_V3-V4 | - | - |
S_SRP338297.SRR16016324 | Oral | Saliva | 2020 | 16S_V3-V4 | - | - |
S_SRP338297.SRR16016325 | Oral | Saliva | 2020 | 16S_V3-V4 | - | - |
S_SRP338297.SRR16016326 | Oral | Saliva | 2020 | 16S_V3-V4 | - | - |
1MNS (Microbiome Novelty Score): < 0.12: Non-novel; 0.12-0.2: Novel; > 0.2: Very novel; -: NA for samples before 2010
2MAS (Microbiome Attention Score): < 10: Low-attention; ≥ 10: High-attention; -: NA for samples before 2010